Silly To Bet Against Lilly
Pharmaceutical giants Eli Lilly and Novo Nordisk both soared to all-time highs today. Let’s see what drove them higher. 👀
Firstly, Novo Nordisk’s closely watched “SELECT” trial results exceeded analyst expectations. They were so good the company’s executive vice president of development said the results show its obesity drug “has the potential to change how obesity is regarded and treated.”